ASCO 2026

BEIJING, Aug. 4, 2026 InnoCare Pharma announced that the China National Medical Products Administration (NMPA) Center for Drug Evaluation...

NORWOOD, Mass., July 28, 2026 Corbus Pharmaceuticals Holdings, Inc. has received U.S. Food and Drug Administration (FDA) clearance to...

ROCKVILLE, Md. & SHANGHAI, July 20, 2026 AbelZeta Pharma, Inc. has achieved a significant regulatory milestone after the European...

SAN ANTONIO, July 20, 2026 Valion Bio, Inc. has announced a significant clinical development milestone after Sheba Medical Center,...

MUMBAI, India & NAPLES, Fla., July 21, 2026 Lupin Limited has announced the strategic spin-out of two promising clinical-stage...

CHICAGO, Ill., June 20, 2026 Avance Clinical, a leading global Contract Research Organization (CRO) specializing in accelerating clinical development...

AUSTIN, Texas, June 9, 2026 Zetagen Therapeutics announced preliminary topline results from its Phase 2a clinical study evaluating ZetaMet™...

SHANGHAI, China, June 8, 2026 OriCell Therapeutics has achieved a major regulatory and clinical milestone with the National Medical...

CHICAGO, Illinois, USA, June 2, 2026 AstraZeneca has announced compelling new results from its pivotal Phase III SERENA-6 trial,...

WALTHAM, Massachusetts, USA, June 2, 202 Stelexis BioSciences has announced encouraging Phase 1 clinical trial results for eganelisib, its...